Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

245.37 +2.39 (+0.98%)
Streaming Delayed Price Updated: 1:40 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 347,366
Open 243.19
Bid (Size) 245.26 (2)
Ask (Size) 245.49 (1)
Prev. Close 242.98
Today's Range 240.46 - 245.41
52wk Range 132.24 - 255.18
Shares Outstanding 146,234,244
Dividend Yield 0.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why ResMed Stock Tumbled by 5% Today
A looming threat from a very powerful rival could significantly dampen a key business for the company. 
Via The Motley Fool
Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?
Wall Street is jittery hours before the highly anticipated Federal Open Market Committee (FOMC) meeting, with all major indices posting modest losses by midday in New York. 
Via Benzinga
Topics Economy
Exposures Interest Rates

Performance

YTD
+42.84%
+42.84%
1 Month
+9.96%
+9.96%
3 Month
+15.05%
+15.05%
6 Month
+26.65%
+26.65%
1 Year
+73.87%
+73.87%

More News

Read More
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
From ResMed Inc.
Via GlobeNewswire
Vaping Expected to Increase COPD Health and Economic Burden by 2050
From ResMed Inc.
Via GlobeNewswire
Reasonable growth and debt and a high ROIC for RESMED INC (NYSE:RMD).
Via Chartmill
How Is The Market Feeling About ResMed?
Via Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Via Benzinga
A Glimpse Into The Expert Outlook On ResMed Through 6 Analysts
Via Benzinga
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
RxSight Stock Sees Relative Strength Rating Rise To 91
Via Investor's Business Daily
Why Quality-Oriented Investors Should Consider NYSE:RMD.
Via Chartmill
NYSE:RMD may be ready to breakout.
Via Chartmill
Uncovering Dividend Opportunities with NYSE:RMD.
Via Chartmill
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
From ResMed Inc.
Via GlobeNewswire
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
Via Benzinga
ResMed's Options Frenzy: What You Need to Know
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
Via Benzinga
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
What 6 Analyst Ratings Have To Say About ResMed
Via Benzinga
Looking Into ResMed's Recent Short Interest
Via Benzinga
Stock Market News From Amazon, Nike, McCormick, and More
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.